General information about company |
|
|---|---|
| Scrip code | 533259 |
| NSE Symbol | SASTASUNDR |
| MSEI Symbol | NOTLISTED |
| ISIN | INE019J01013 |
| Name of company | SASTASUNDAR VENTURES LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-Apr-2024 |
| Date of end of financial year | 31-Mar-2025 |
| Date of board meeting when results were approved | 30-May-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 22-May-2025 |
| Description of presentation currency | INR (in Actuals) |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 30-May-2025 15:30:00 |
| End date and time of board meeting | 30-May-2025 19:15:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
Financial Results — NBFC |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | |||
| (i) | Interest Income | 1859000 | 7571000 |
| (ii) | Dividend Income | 0 | 3038000 |
| (iii) | Rental Income | 0 | 0 |
| (iv) | Fees and commission Income | 0 | 0 |
| (v) | Net gain on fair value changes | 37113000 | 214240000 |
| (vi) | Net gain on derecognition of financial instruments under amortised cost category | 0 | 0 |
| (vii) | Sale of products (including Excise Duty) | 2812432000 | 10849821000 |
| (viii) | Sale of services | 6887000 | 31308000 |
| (ix) | Other revenue from operations | ||
| 1 | Other Financial Income | 114000 | 3568000 |
| Total other revenue from operations | 114000 | 3568000 | |
| Total Revenue From Operations | 2858405000 | 11109546000 | |
| Other income | 216274000 | 598405000 | |
| Total income | 3074679000 | 11707951000 | |
| 2 | Expenses | ||
| Cost of materials consumed | 3095000 | 17410000 | |
| Purchases of stock-in-trade | 2686539000 | 10157748000 | |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | -36679000 | -1057000 | |
| Employee benefit expense | 163127000 | 497932000 | |
| Finance costs | 130000 | 2172000 | |
| Depreciation, depletion and amortisation expense | 13368000 | 58288000 | |
| Fees and commission expense | 0 | 0 | |
| Net loss on fair value changes | 0 | 0 | |
| Net loss on derecognition of financial instruments under amortised cost category | 0 | 0 | |
| Impairment on financial instruments | 0 | 0 | |
| (f) | Other expenses | ||
| 1 | Other Expenses | 294245000 | 997777000 |
| Total other expenses | 294245000 | 997777000 | |
| Total expenses | 3123825000 | 11730270000 | |
| 3 | Total profit before exceptional items and tax | -49146000 | -22319000 |
| 4 | Exceptional items | 2800000 | -1906291000 |
| 5 | Total profit before tax | -46346000 | -1928610000 |
| 7 | Tax expense | ||
| 8 | Current tax | -113937000 | 41311000 |
| 9 | Deferred tax | -108130000 | -742531000 |
| 10 | Total tax expenses | -222067000 | -701220000 |
| 11 | Net Profit Loss for the period from continuing operations | 175721000 | -1227390000 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 17 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 14 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | -108040000 |
| 15 | Total profit (loss) for period | 175721000 | -1335430000 |
| 16 | Other comprehensive income net of taxes | -7204000 | -4480000 |
| 17 | Total Comprehensive Income for the period | 168517000 | -1339910000 |
| 18 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 136720000 | -911671000 | |
| Total profit or loss, attributable to non-controlling interests | 39001000 | -423759000 | |
| 19 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | -5311000 | -3281000 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | -1893000 | -1199000 | |
| 20 | Details of equity share capital | ||
| Paid-up equity share capital | 318105000 | 318105000 | |
| Face value of equity share capital | 10 | 10 | |
| 21 | Reserves excluding revaluation reserve | 6380605000 | |
| 22 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings per share from continuing operations | 4.3 | -28.66 | |
| Diluted earnings per share from continuing operations | 4.3 | -28.66 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings per share from discontinued operations | 0 | 0 | |
| Diluted earnings per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings per share | 4.3 | -28.66 | |
| Diluted earnings per share | 4.3 | -28.66 | |
| 23 | Debt equity ratio | ||
| 24 | Debt service coverage ratio | ||
| 25 | Interest service coverage ratio | ||
| 26 | Disclosure of notes on financial results | ||
Remarks |
||
|---|---|---|
| 23 | Debt equity ratio | |
| 24 | Debt service coverage ratio | |
| 25 | Interest service coverage ratio | |
Cash flow statement, indirect |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| A | Date of start of reporting period | 01-Apr-2024 | |
| B | Date of end of reporting period | 31-Mar-2025 | |
| C | Whether results are audited or unaudited | Audited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Part I | Blue color marked fields are non-mandatory. | ||
| Statement of cash flows | |||
| Cash flows from used in operating activities | |||
| Profit before tax | -1928610000 | ||
| Adjustments for reconcile profit (loss) | |||
| Adjustments for finance costs | 2172000 | ||
| Adjustments for decrease (increase) in inventories | 55004000 | ||
| Adjustments for decrease (increase) in trade receivables, current | 203180000 | ||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | ||
| Adjustments for decrease (increase) in other current assets | 0 | ||
| Adjustments for decrease (increase) in other non-current assets | 0 | ||
| Adjustments for other financial assets, non-current | 19214000 | ||
| Adjustments for other financial assets, current | 0 | ||
| Adjustments for other bank balances | 269431000 | ||
| Adjustments for increase (decrease) in trade payables, current | 0 | ||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | ||
| Adjustments for increase (decrease) in other current liabilities | -39904000 | ||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | ||
| Adjustments for depreciation and amortisation expense | 58288000 | ||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | ||
| Adjustments for provisions, current | -7738000 | ||
| Adjustments for provisions, non-current | 14000 | ||
| Adjustments for other financial liabilities, current | 27799000 | ||
| Adjustments for other financial liabilities, non-current | 0 | ||
| Adjustments for unrealised foreign exchange losses gains | 0 | ||
| Adjustments for dividend income | 3038000 | ||
| Adjustments for interest income | 151261000 | ||
| Adjustments for share-based payments | 0 | ||
| Adjustments for fair value losses (gains) | -219368000 | ||
| Adjustments for undistributed profits of associates | 0 | ||
| Other adjustments for which cash effects are investing or financing cash flow | -317010000 | ||
| Other adjustments to reconcile profit (loss) | 1906291000 | ||
| Other adjustments for non-cash items | -2968000 | ||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | ||
| Total adjustments for reconcile profit (loss) | 1800106000 | ||
| Net cash flows from (used in) operations | -128504000 | ||
| Dividends received | 0 | ||
| Interest paid | 0 | ||
| Interest received | 0 | ||
| Income taxes paid (refund) | 44582000 | ||
| Other inflows (outflows) of cash | 0 | ||
| Net cash flows from (used in) operating activities | -173086000 | ||
| Cash flows from used in investing activities | |||
| Cash flows from losing control of subsidiaries or other businesses | 0 | ||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | ||
| Other cash receipts from sales of equity or debt instruments of other entities | 6624564000 | ||
| Other cash payments to acquire equity or debt instruments of other entities | 7079757000 | ||
| Other cash receipts from sales of interests in joint ventures | 0 | ||
| Other cash payments to acquire interests in joint ventures | 0 | ||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | ||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | ||
| Proceeds from sales of property, plant and equipment | 2853000 | ||
| Purchase of property, plant and equipment | 103566000 | ||
| Proceeds from sales of investment property | 0 | ||
| Purchase of investment property | 0 | ||
| Proceeds from sales of intangible assets | 0 | ||
| Purchase of intangible assets | 0 | ||
| Proceeds from sales of intangible assets under development | 0 | ||
| Purchase of intangible assets under development | 0 | ||
| Proceeds from sales of goodwill | 0 | ||
| Purchase of goodwill | 0 | ||
| Proceeds from biological assets other than bearer plants | 0 | ||
| Purchase of biological assets other than bearer plants | 0 | ||
| Proceeds from government grants | 0 | ||
| Proceeds from sales of other long-term assets | 0 | ||
| Purchase of other long-term assets | 0 | ||
| Cash advances and loans made to other parties | 0 | ||
| Cash receipts from repayment of advances and loans made to other parties | 0 | ||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | ||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | ||
| Dividends received | 3038000 | ||
| Interest received | 117702000 | ||
| Income taxes paid (refund) | 0 | ||
| Other inflows (outflows) of cash | 423825000 | ||
| Net cash flows from (used in) investing activities | -11341000 | ||
| Cash flows from used in financing activities | |||
| Proceeds from changes in ownership interests in subsidiaries | 0 | ||
| Payments from changes in ownership interests in subsidiaries | 0 | ||
| Proceeds from issuing shares | 0 | ||
| Proceeds from issuing other equity instruments | 0 | ||
| Payments to acquire or redeem entity's shares | 0 | ||
| Payments of other equity instruments | 0 | ||
| Proceeds from exercise of stock options | 0 | ||
| Proceeds from issuing debentures notes bonds etc | 0 | ||
| Proceeds from borrowings | 0 | ||
| Repayments of borrowings | 0 | ||
| Payments of lease liabilities | 3826000 | ||
| Dividends paid | 0 | ||
| Interest paid | 605000 | ||
| Income taxes paid (refund) | 0 | ||
| Other inflows (outflows) of cash | 0 | ||
| Net cash flows from (used in) financing activities | -4431000 | ||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -188858000 | ||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Effect of exchange rate changes on cash and cash equivalents | 0 | ||
| Net increase (decrease) in cash and cash equivalents | -188858000 | ||
| Cash and cash equivalents cash flow statement at beginning of period | 313073000 | ||
| Cash and cash equivalents cash flow statement at end of period | 124215000 | ||
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Finanical Asset | ||
| Cash and cash equivalents | 124215000 | ||
| Bank Balance other than (a) above | 221000 | ||
| Derivative financial instruments | |||
| Receivables | |||
| (I) Trade Receivables | 99758000 | ||
| (II) Other Receivables | |||
| Loans | 89896000 | ||
| Investments | 5754199000 | ||
| Other Financial assets | 899089000 | ||
| Total Financial Assets | 6967378000 | ||
| 2 | Non Financial Asset | ||
| Inventories | 1102943000 | ||
| Current tax assets (Net) | 70932000 | ||
| Deferred tax Assets (Net) | 112105000 | ||
| Investment Property | 23294000 | ||
| Biological assets other than bearer plants | |||
| Property, Plant and Equipment | 633658000 | ||
| Capital work-in-progress | 102378000 | ||
| Intangible assets under development | |||
| Goodwill | 361434000 | ||
| Other Intangible assets | 792000 | ||
| Other non-financial assets (to be specified) | 368800000 | ||
| Total Non Financial Assets | 2776336000 | ||
| Total assets | 9743714000 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 318105000 | ||
| Other equity | 6380605000 | ||
| Total equity attributable to owners of parent | 6698710000 | ||
| Non controlling interest | 1946639000 | ||
| Total equity | 8645349000 | ||
| 2 | Liabilities | ||
| 2.1 | Financial Liabilities | ||
| (a) | Derivative financial instruments | 0 | |
| (b) | Payables | ||
| (I)Trade Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 190358000 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 397178000 | ||
| II) Other Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 0 | ||
| (C ) | Debt Securities | 0 | |
| (d) | Borrowings (Other than Debt Securities) | 0 | |
| (e) | Deposits | 0 | |
| (f) | Subordinated Liabilities | 0 | |
| (g) | Other financial liabilities | 291872000 | |
| Total Financial Liabilities | 879408000 | ||
| 2.2 | Non-Financial Liabilities | ||
| (a) | Current tax liabilities (Net) | 54061000 | |
| (b) | Provisions | 72173000 | |
| (C ) | Deferred tax liabilities (Net) | 39686000 | |
| (d) | Other non-financial liabilities | 53037000 | |
| Total Non Financial Liabilities | 218957000 | ||
| Total liabilities | 1098365000 | ||
| Total equity and liabilites | 9743714000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| Whether accounts are audited or unaudited | Audited | Audited | |
| Nature of report standalone or consolidated | Consolidated | Consolidated | |
| 1 | Segment Revenue (Income) | ||
| (net sale/income from each segment should be disclosed) | |||
| 1 | Financial Services | 39093000 | 228416000 |
| 2 | Healthcare Network | 2819312000 | 10881130000 |
| Total Segment Revenue | 2858405000 | 11109546000 | |
| Less: Inter segment revenue | |||
| Revenue from operations | 2858405000 | 11109546000 | |
| 2 | Segment Result | ||
| Profit (+) / Loss (-) before tax and interest from each segment | |||
| 1 | Financial Services | 35772000 | 205305000 |
| 2 | Healthcare Network | -189434000 | -2593137000 |
| Total Profit before tax | -153662000 | -2387832000 | |
| i. Finance cost | |||
| ii. Other Unallocable Expenditure net off Unallocable income | |||
| Profit before tax | -153662000 | -2387832000 | |
| 3 | (Segment Asset - Segment Liabilities) | ||
| Segment Asset | |||
| 1 | Financial Services | 1014680000 | 1014680000 |
| 2 | Healthcare Network | 8249070000 | 8249070000 |
| Total Segment Asset | 9263750000 | 9263750000 | |
| Un-allocable Assets | 479964000 | 479964000 | |
| Net Segment Asset | 9743714000 | 9743714000 | |
| 4 | Segment Liabilities | ||
| Segment Liabilities | |||
| 1 | Financial Services | 45181000 | 45181000 |
| 2 | Healthcare Network | 1039870000 | 1039870000 |
| Total Segment Liabilities | 1085051000 | 1085051000 | |
| Un-allocable Liabilities | 13314000 | 13314000 | |
| Net Segment Liabilities | 1098365000 | 1098365000 | |
| Disclosure of notes on segments | |||
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Jan-2025 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Items that will be not reclassified subsequently to profit or loss | -9500000 | -6718000 |
| Total Amount of items that will not be reclassified to profit and loss | -9500000 | -6718000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -2296000 | -2238000 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | ||
| 5 | Total Other comprehensive income | -7204000 | -4480000 |
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | J K V S & CO | Yes | 30-Nov-2027 | ||
|---|---|---|---|---|---|